Prospective Comparison of Two Robotic Platforms for the Performance of Radical Prostatectomy: Versius vs. DaVinci
Cancers · 20.11.2026 · 18 (22) · 3710
DOI: 10.3390/cancers18223710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 20.11.2026. Verfasst von Sara Garach Fernández und 4 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: To compare the perioperative, oncological, and functional outcomes of the Versius® and DaVinci® systems as used for performing robot-assisted radical prostatectomy (RARP) in patients with localized prostate cancer.
Methods
Prospective observational comparative study of 278 patients subjected to RARP between March 2023 and September 2025. 169 procedures were performed with the Versius® system and 109 with the DaVinci® system. An analysis was performed of a series of demographic, perioperative, pathological, and functional variables. Quantitative variables were compared using either Student’s t or the Mann–Whitney Test, while categorical variables were analyzed with the chi-squared test or Fisher’s Exact Test.
Results
Both groups exhibited comparable baseline characteristics. No significant differences were observed in lymphadenectomy rates, perioperative complications, transfusion requirements, length of hospital stay, or postoperative PSA levels. The DaVinci® group showed higher rates of neurovascular bundle preservation (48.6% vs. 17.4%; p < 0.001) and greater lymph node yield (14.27 vs. 10.78 nodes; p < 0.001). Pathological lymph node involvement (pN1) was more frequent in the DaVinci® group (20.4% vs. 5.1%; p = 0.019). No significant differences were observed in positive surgical margins, pathological T stage, or specimen ISUP grade. Urinary incontinence was more frequent in the Versius® group at 3 and 6 months (p = 0.003 and p = 0.034, respectively), with no statistically significant difference at 12 months.
Conclusions
Both Versius® and DaVinci® were shown to be safe and effective platforms for the performance of RARP, with comparable short-term perioperative and oncological outcomes.
Zitieren
APA
Fernández, S. G., Barreras, S. G., Serrano, G. M., Conejo, G. F., & Revilla, F. J. B. (2026). Prospective Comparison of Two Robotic Platforms for the Performance of Radical Prostatectomy: Versius vs. DaVinci. Cancers, 18(22), 3710. https://doi.org/10.3390/cancers18223710
Vancouver
Fernández SG, Barreras SG, Serrano GM, Conejo GF, Revilla FJB. Prospective Comparison of Two Robotic Platforms for the Performance of Radical Prostatectomy: Versius vs. DaVinci. Cancers. 2026;18(22):3710. doi:10.3390/cancers18223710
BibTeX
@article{Fernndez2026,
author = {Fernández, Sara Garach and Barreras, Silvia García and Serrano, Gema Martín and Conejo, Guillermo Fernández and Revilla, Francisco Javier Burgos},
title = {Prospective Comparison of Two Robotic Platforms for the Performance of Radical Prostatectomy: Versius vs. DaVinci},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3710},
doi = {10.3390/cancers18223710}
}
EUVIMED